Resistance emerges to second-generation antiandrogens in prostate cancer.

Resistance emerges to second-generation antiandrogens in prostate cancer.

Item
http://www.wikidata.org/entity/Q34369873
Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapiesBeyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer MeetingDual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer.miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src.Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy.Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.Genome-Wide Methylation Patterns in Androgen-Independent Prostate Cancer Cells: A Comprehensive Analysis Combining MeDIP-Bisulfite, RNA, and microRNA Sequencing Data.TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.Frequently rearranged and overexpressed δ-catenin is responsible for low sensitivity of prostate cancer cells to androgen receptor and β-catenin antagonists.Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo.
P2860

Resistance emerges to second-generation antiandrogens in prostate cancer.

Item
http://www.wikidata.org/entity/Q34369873
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Resistance emerges to second-generation antiandrogens in prostate cancer.
@ast
Resistance emerges to second-generation antiandrogens in prostate cancer.
@en
Resistance emerges to second-generation antiandrogens in prostate cancer.
@nl
type
label
Resistance emerges to second-generation antiandrogens in prostate cancer.
@ast
Resistance emerges to second-generation antiandrogens in prostate cancer.
@en
Resistance emerges to second-generation antiandrogens in prostate cancer.
@nl
prefLabel
Resistance emerges to second-generation antiandrogens in prostate cancer.
@ast
Resistance emerges to second-generation antiandrogens in prostate cancer.
@en
Resistance emerges to second-generation antiandrogens in prostate cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Resistance emerges to second-generation antiandrogens in prostate cancer.
@en
P2093
P2860
P304
P31
P356
10.1158/2159-8290.CD-13-0405
P433
P478
P577
P698
P932